iBio, Inc. (IBIO) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of iBio, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IBIO
iBio, Inc.
$1.06HealthcareDelayed quote: Oct 6, 2026, 12:05 PM EDT
PDSB
PDS Biotechnology Corporation
$1.08HealthcareDelayed quote: Oct 6, 2026, 12:00 PM EDT
Total return — IBIO vs PDSB
growth of $100 · dividends reinvested · last 10yIBIO -100.0% (-54.1%/yr)PDSB -99.5% (-40.6%/yr)PDSB compounded faster over this window
Log scale — wide-divergence pair
IBIO PDSB
IBIO vs PDSB: by the numbers
- •IBIO is the larger company ($68M vs $60M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -33044.00% net margin).
Metrics side by side
Valuation
| Metric | IBIO | PDSB |
|---|---|---|
| P/S ratio | 678.44 | N/A |
| P/B ratio | 0.79 | N/A |
Profitability
| Metric | IBIO | PDSB |
|---|---|---|
| Gross margin | 100.00% | 0.00% |
| Operating margin | -35141.00% | 0.00% |
| Net margin | -33044.00% | 0.00% |
| ROE | -38.55% | N/A |
| ROIC | -40.22% | -3699.99% |
Growth (annualized)
| Metric | IBIO | PDSB |
|---|---|---|
| Revenue CAGR (5Y) | -46.91% | N/A |
| Total return CAGR (5Y) | -70.43% | -39.13% |
Frequently asked
- How have IBIO and PDSB total returns compared?
- Over the past 10 years, IBIO delivered -54.11% and PDSB delivered -40.75% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.